Cefzil

   
Google
 
Web NewDrugInformation.com

Cefzil


Drug - Cefzil
The trade name of the product as shown on the labeling.

Dosage - FOR SUSPENSION; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Cefprozil
Multiple ingredients are in alphabetical order.

Strength - 250MG/5ML
The potency of the active ingredient(s), Cefprozil. May repeat for multiple part products.

Applicant - BRISTOL MYERS SQUIBB
The firm name holding legal responsibility for Cefzil. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 050665
The FDA assigned number to Cefzil. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Cefzil. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 23, 1991
The date Cefzil was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Cefzil. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Cefzil is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bristol Myers Squibb Co Pharmaceutical Research Institute
The full name of the firm holding legal responsibility for the new application of Cefzil.

Cefzil